Cosmos Pharmaceutical Corp Forecast, price target & analysts
Why the stock moved Beta
Cosmos Pharmaceutical Corp Target price 2026 - Analyst rating & recommendation
Cosmos Pharmaceutical Corp Classifications & Recommendation
Cosmos Pharmaceutical Corp Price Target
| Target Price | ¥7,956.00 |
| Price | ¥6,436.00 |
| Potential |
23.62%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Cosmos Pharmaceutical Corp 2027 .
The average Cosmos Pharmaceutical Corp target price is ¥7,956.00.
This is
23.62%
register free of charge
¥10,500.00
63.14%
register free of charge
¥6,767.00
5.14%
register free of charge
|
|
| A rating was issued by 15 analysts: 9 Analysts recommend Cosmos Pharmaceutical Corp to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cosmos Pharmaceutical Corp stock has an average upside potential 2027 of
23.62%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| May '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 1,099.58 | 1,195.79 |
| 8.72% | 8.75% | |
| EBITDA Margin | 5.91% | 5.98% |
| 1.76% | 1.17% | |
| Net Margin | 2.91% | 2.69% |
| 4.85% | 7.70% |
12 Analysts have issued a sales forecast Cosmos Pharmaceutical Corp 2027 . The average Cosmos Pharmaceutical Corp sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Cosmos Pharmaceutical Corp EBITDA forecast 2027. The average Cosmos Pharmaceutical Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Cosmos Pharmaceutical Corp Analysts have issued a net profit forecast 2027. The average Cosmos Pharmaceutical Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| May '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 404.33 | 406.02 |
| 3.45% | 0.42% | |
| P/E | 15.85 | |
| EV/Sales | 0.46 |
12 Analysts have issued a Cosmos Pharmaceutical Corp forecast for earnings per share. The average Cosmos Pharmaceutical Corp EPS is
This results in the following potential growth metrics and future valuations:
Cosmos Pharmaceutical Corp...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
